HPL Pharmaceuticals: Major
Health Technology
Mkt Cap
38.7B
P/E (TTM)
12.64
EPS
300.69
ROE
37.58%
Div Yield
5.99%
About
Hoechst Pakistan Ltd. engages in the manufacturing, selling, and trading of pharmaceutical and related products. It operates through the Pakistan and Afghanistan geographical segments. The company was founded on December 8, 1967 and is headquartered in Karachi, Pakistan.
Financial Highlights
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Revenue | 30.96B | 26.75B | 21.37B | 18.56B | 15.88B | |
| Gross Profit | 11.31B | 8.13B | 5.37B | 4.73B | 3.93B | |
| Net Income | 2.90B | 1.86B | 360.81M | 166.78M | 905.95M | |
| EPS | 300.69 | 192.56 | 37.41 | 17.29 | 93.93 | |
| ROE | 38.65% | 30.23% | 6.87% | 3.25% | 18.53% | |
| ROA | 20.59% | 15.73% | 3.23% | 1.54% | 10.06% | |
| Gross Margin | 36.55% | 30.38% | 25.11% | 25.49% | 24.77% | |
| Net Margin | 9.37% | 6.94% | 1.69% | 0.90% | 5.70% | |
| Current Ratio | 1.71 | 1.68 | 1.78 | 1.41 | 1.83 | |
| DPS | 240.00 | 135.00 | 30.00 | 0.00 | 30.00 | |
| Free Cash Flow | 3.41B | -1.34B | 2.26B | -1.84B | 1.23B |